首页> 外文期刊>The pharmaceutical journal >Will the new kid on the anticoagulant block steal the limelight from warfarin?
【24h】

Will the new kid on the anticoagulant block steal the limelight from warfarin?

机译:服用抗凝药的新生孩子会不会从华法林身上抢走风头?

获取原文
获取原文并翻译 | 示例
           

摘要

Maybe I need to get out more,but I am quite excited-there is a new drug that,in my opinion,really makes the huge sums of money,time and intellectual ef-fort invested in drug development worthwhile.As I flick through the pages of the various journals that land on my desk,most pharmaceutical advertisements warrant,at best,only a cursory glance and the page is often turned with a thought along the lines of"why on earth do we need another angiotensin II receptor antagonist?".Recently,however,some of these pages have triggered a much more positive and hopeful outlook.
机译:也许我需要更多,但我感到很兴奋-我认为,有一种新药确实使投入药物开发的大量金钱,时间和知识努力值得。放在我桌上的各种期刊的页面,大多数医药广告充其量,充其量只是乍一看,而该页面的想法常常是“为什么我们需要另一种血管紧张素II受体拮抗剂?”。然而,最近,其中一些页面引发了更加积极和希望的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号